Analysing the Shift in Prescribing Patterns: Sodium Glucose Co-transporter 2 Inhibitors, Dipeptidyl Peptidase 4 Inhibitors and Traditional Antidiabetic Drugs.
No Thumbnail Available
Date
2025-03
Journal Title
Journal ISSN
Volume Title
Publisher
Light House Polyclinic
Abstract
Abstract: India currently has around 77 million adults living with diabetes. Considering the growing impact of diabetesrelated complications, we aimed to compare the real-world prescribing patterns of sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors and traditional antidiabetics. Using a cross-sectional study design, the prescribing pattern and factors influencing the utilisation of the antidiabetic drugs, categorised by the HbA1c status, were assessed using the chi-square test. Of 260 eligible adults with mean [SD] age, 63.7[12.4] years; 54.7% of male participants initiated treatment with sodium-glucose cotransporter-2 inhibitors (n=27) or a dipeptidyl peptidase-4 inhibitors (n=31). The use of newer antidiabetic agents has steadily increased, with a slightly higher initiation rate in those over 65 years (21.5%). No significant difference was observed based on age (p = 0.182) or gender (p = 0.9548). Prescriber speciality had a significant impact (p = 0.00038). Cardiologists showed the highest shift towards newer drugs (36.5%). Prescriptions of newer antidiabetics have shown an upward trend over time, indicating a shift in prescribing practices. However, this increase was limited. Further efforts are necessary to identify and address the barriers to underutilisation of these drugs
Description
Keywords
Dipeptidyl peptidase inhibitors, HbA1c, Prescribing pattern, Sodium glucose cotransporter 2 inhibitors, Type 2 Diabetes Mellitus.
Citation
Pavithran V, Balachandran P, Sajeeth CI, Hariharan A. Analysing the Shift in Prescribing Patterns: Sodium Glucose Co-transporter 2 Inhibitors, Dipeptidyl Peptidase 4 Inhibitors and Traditional Antidiabetic Drugs.. Online Journal of Health and Allied Sciences. 2025 Mar; 24(93): 1-6